Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symptom Based Performance of Airway Clearance Therapy After Starting Highly Effective CFTR Modulator Therapy for Cystic Fibrosis

NCT05392855 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT05392855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05392855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symptom Based Performance of Airway Clearance Therapy After Starting Highly Effective CFTR Modulator Therapy for Cystic Fibrosis
Lead sponsor
University of Missouri-Columbia
Phase
Not applicable
Overall status
Terminated
Start date
September 5, 2023
Completion date
September 18, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, mucociliary clearance defect